Д. А. Андреев

705 total citations
76 papers, 298 citations indexed

About

Д. А. Андреев is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Д. А. Андреев has authored 76 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Cardiology and Cardiovascular Medicine, 9 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Surgery. Recurrent topics in Д. А. Андреев's work include Atrial Fibrillation Management and Outcomes (21 papers), Antiplatelet Therapy and Cardiovascular Diseases (19 papers) and Heart Failure Treatment and Management (8 papers). Д. А. Андреев is often cited by papers focused on Atrial Fibrillation Management and Outcomes (21 papers), Antiplatelet Therapy and Cardiovascular Diseases (19 papers) and Heart Failure Treatment and Management (8 papers). Д. А. Андреев collaborates with scholars based in Russia, United States and Switzerland. Д. А. Андреев's co-authors include Д. А. Сычев, К. Б. Мирзаев, Е. А. Гришина, Dmitry Shchekochikhin, Smirnov Vv, Syrkin Al, Hugo Saner, A. V. Ryabova, Philipp Kopylov and А. Yu. Suvorov and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Д. А. Андреев

65 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Д. А. Андреев Russia 9 208 54 37 30 30 76 298
Kun-Tai Lee Taiwan 11 402 1.9× 31 0.6× 35 0.9× 22 0.7× 19 0.6× 18 511
Yilun Zhou China 12 106 0.5× 37 0.7× 72 1.9× 35 1.2× 8 0.3× 35 270
Gyu Chul Oh South Korea 11 183 0.9× 35 0.6× 50 1.4× 16 0.5× 6 0.2× 34 313
Jean-Pierre Boissel France 7 521 2.5× 50 0.9× 109 2.9× 59 2.0× 42 1.4× 12 633
Henry Yu United States 6 259 1.2× 111 2.1× 53 1.4× 38 1.3× 11 0.4× 8 478
Kazuaki Uchiyama Japan 8 105 0.5× 50 0.9× 105 2.8× 14 0.5× 8 0.3× 13 302
Payman Shahabi Iran 10 63 0.3× 44 0.8× 55 1.5× 27 0.9× 29 1.0× 26 305
Tine L. De Backer Belgium 14 424 2.0× 117 2.2× 95 2.6× 56 1.9× 83 2.8× 25 534
Kazuhito Shiosakai Japan 15 151 0.7× 133 2.5× 107 2.9× 65 2.2× 44 1.5× 58 544
Cristina Varas Spain 6 137 0.7× 203 3.8× 89 2.4× 12 0.4× 17 0.6× 10 427

Countries citing papers authored by Д. А. Андреев

Since Specialization
Citations

This map shows the geographic impact of Д. А. Андреев's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Д. А. Андреев with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Д. А. Андреев more than expected).

Fields of papers citing papers by Д. А. Андреев

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Д. А. Андреев. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Д. А. Андреев. The network helps show where Д. А. Андреев may publish in the future.

Co-authorship network of co-authors of Д. А. Андреев

This figure shows the co-authorship network connecting the top 25 collaborators of Д. А. Андреев. A scholar is included among the top collaborators of Д. А. Андреев based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Д. А. Андреев. Д. А. Андреев is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shchekochikhin, Dmitry, et al.. (2024). Venous Excess Ultrasound Score Is Associated with Worsening Renal Function and Reduced Natriuretic Response in Patients with Acute Heart Failure. Journal of Clinical Medicine. 13(20). 6272–6272. 6 indexed citations
2.
Shchekochikhin, Dmitry, et al.. (2024). Hemodynamic Changes in Intrarenal Blood Flow are Associated With Poor Prognosis in Patients With Acute Decompensated Heart Failure. Kardiologiia. 64(4). 38–44. 1 indexed citations
4.
Shchekochikhin, Dmitry, et al.. (2023). Natriuresis as a Way to Assess the Effectiveness of Diuretic Therapy for Acute Decompensated Heart Failure: Data from a Pilot Study. SHILAP Revista de lepidopterología. 18(6). 656–661. 1 indexed citations
5.
Новикова, Н. А., et al.. (2023). The use of Dapagliflozin in Acute Decompensated Heart Failure: Results of the Randomized Study. Kardiologiia. 63(8). 11–18. 4 indexed citations
6.
Volel, B. A., et al.. (2023). Clinical features of asthenic disorders in chronic heart failure. S S Korsakov Journal of Neurology and Psychiatry. 123(2). 104–104. 3 indexed citations
7.
Shchekochikhin, Dmitry, et al.. (2022). Long-term prognosis in patients with tachycardia-induced cardiomyopathy. Russian Journal of Cardiology and Cardiovascular Surgery. 15(5). 508–508.
8.
Kopylov, Philipp, et al.. (2022). Impact of anxiety disorders on adherence to anticoagulant therapy in patients with atrial fibrillation. Terapevticheskii arkhiv. 94(9). 1085–1093. 1 indexed citations
9.
Андреев, Д. А., et al.. (2022). Clinical and psychopathological aspects of nosogenic reactions in chronic heart failure. S S Korsakov Journal of Neurology and Psychiatry. 122(9). 86–86. 2 indexed citations
10.
Андреев, Д. А., et al.. (2022). Social and psychological risk factors for decreased adherence among patients with atrial fibrillation. Terapevticheskii arkhiv. 94(10). 1197–1203. 1 indexed citations
11.
Zheludkova, Olga, et al.. (2022). Risk factors for cardiovascular diseases in patients received complex treatment for cranial and craniospinal tumors in childhood. SHILAP Revista de lepidopterología. 27(11). 5175–5175. 3 indexed citations
12.
Новикова, Н. А., et al.. (2021). Dynamics of Kidney Function in Patients with Chronic Kidney Disease and Atrial Fibrillation Who Receive Dabigatran. SHILAP Revista de lepidopterología. 17(2). 186–192. 1 indexed citations
13.
Андреев, Д. А., et al.. (2018). Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke. SHILAP Revista de lepidopterología. 16 indexed citations
14.
Мирзаев, К. Б., et al.. (2018). The ABCB1 , CYP2C19 , CYP3A5 and CYP4F2 genetic polymorphisms and platelet reactivity in the early phases of acute coronary syndromes. Drug Metabolism and Personalized Therapy. 33(3). 109–118. 6 indexed citations
16.
Дамулин, И В, et al.. (2015). The fibrillation of atrium and stroke. 21(6). 41–45. 1 indexed citations
17.
Мирзаев, К. Б., Д. А. Сычев, & Д. А. Андреев. (2015). GENETICS OF CLOPIDOGREL RESISTANCE: RECENT DATA. SHILAP Revista de lepidopterología. 92–92. 1 indexed citations
18.
Андреев, Д. А., et al.. (2009). Physical training in patients with chronic heart failure. SHILAP Revista de lepidopterología. 1 indexed citations
19.
Кукес, В. Г., et al.. (2008). Cytochrome P-450 3A4 system in patients with acute myocardial infarction. SHILAP Revista de lepidopterología. 1 indexed citations
20.
Андреев, Д. А. & Yi Liang. (2008). Clinical random control observation of 18 cases of the patient with syndrome of primary IgA nephropathy to be treated by tablet tripterygium glocosides. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026